SCHEMBL14356342

SCHEMBL14356342

COc1ccc2c(c1)nc([S+]([O-])Cc1ncc(C)c(OC)c1C)n2S(=O)(=O)c1ccc(CCC(=O)O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.39
PPARA Q07869 5/20 0.39
PPARD Q03181 5/20 0.39
CYP2C9 P11712 2/20 0.39
KMT2A Q03164 3/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 3/20 0.36
WDR5 P61964 2/20 0.36
BRS3 P32247 2/20 0.36
PKM P14618 2/20 0.36
HTT P42858 2/20 0.36
KDM4E B2RXH2 1/20 0.36
DDAH1 O94760 1/20 0.36
ABCB11 O95342 1/20 0.36
ATP1A1 P05023 1/20 0.36
ATP1B1 P05026 1/20 0.36
CYP1A2 P05177 1/20 0.36
CHRM2 P08172 1/20 0.36
ABCB1 P08183 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5370610 0.99 PPARG (0.39) PPARGPPARAPPARDCYP2C9KMT2A
SCHEMBL14356265 0.91 CYP2C9 (0.41) CYP2C9KMT2AMEN1ALDH1A1WDR5
Agn-201904 SCHEMBL5764653 0.90 CYP2C9 (0.41) PPARGPPARAPPARDCYP2C9KMT2A
Agn-201904 SCHEMBL29596867 0.90 CYP2C9 (0.41) PPARGPPARAPPARDCYP2C9KMT2A
Agn-201904 SCHEMBL2245875 0.90 CYP2C9 (0.41) PPARGPPARAPPARDCYP2C9KMT2A
Agn-201904 SCHEMBL5330690 0.90 CYP2C9 (0.41) PPARGPPARAPPARDCYP2C9KMT2A
SCHEMBL5763428 0.90 PPARG (0.39) PPARGPPARAPPARDCYP2C9KMT2A
SCHEMBL7009476 0.90 CYP2C9 (0.45) CYP2C9KMT2AMEN1ALDH1A1WDR5
Agn-201904 SCHEMBL5764638 0.89 CYP2C9 (0.40) PPARGPPARAPPARDCYP2C9KMT2A
SCHEMBL5763408 0.89 PPARG (0.39) PPARGPPARAPPARDCYP2C9KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7294716-B2 Process for preparing isomerically pure prodrugs of proton pump inhibitors ALLERGAN, INC. (US) 2007-11-13 US disclosed
US-7294716-B2 Process for preparing isomerically pure prodrugs of proton pump inhibitors ALLERGAN, INC. (US) 2007-11-13 US disclosed